First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer PatientsXin Zhou(Ministry of Education), Nan Li(Peking University Cancer Hospital)Journal of Nuclear MedicineJuly 29, 202110.2967/jnumed.121.262045Cited by 129SaveCiteExport RISWatch citationsRelated Papers68Ga-grazytracer PET for noninvasive assessment of response to immunotherapy in solid tumors and lymphomas: a phase 1/2 clinical trial|Nature Communications|2024|23